Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C28H44O3 |
| Molecular Weight | 428.6472 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CC[C@@H]3[C@@]4(C)CC[C@H](O)C[C@@]45OO[C@@]23C=C5
InChI
InChIKey=VXOZCESVZIRHCJ-KGHQQZOUSA-N
InChI=1S/C28H44O3/c1-18(2)19(3)7-8-20(4)22-9-10-23-25(22,5)13-12-24-26(6)14-11-21(29)17-27(26)15-16-28(23,24)31-30-27/h7-8,15-16,18-24,29H,9-14,17H2,1-6H3/b8-7+/t19-,20+,21-,22+,23+,24+,25+,26+,27+,28-/m0/s1
| Molecular Formula | C28H44O3 |
| Molecular Weight | 428.6472 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
Ergosterol endoperoxide is a derivative of ergosterol. It has been isolated from a variety of fungi, yeast, lichens and sponges. Ergosterol endoperoxide has been shown to inhibit the growth of some cancer cells and to induce apoptosis of HL60 human leukemia cells. Ergosterol endoperoxide also decreases lipid peroxidation of rat liver microsomes and suppresses the proliferation of mouse and human lymphocytes stimulated with mitogens. It has been reported as having immunosuppressive, antiplasmodial, antimycobacterial, antiviral, anti-inflammatory and antitumoural properties. The interaction of Trypanosoma cruzi with ergosterol peroxide in vitro resulted in a strong lytic activity possibly due to the disruption of the parasite membrane.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Beta-catenin pathway |
|||
Target ID: STAT3 signaling pathway Sources: https://www.ncbi.nlm.nih.gov/pubmed/28761355 |
|||
Target ID: JAK2 signaling pathway Sources: https://www.ncbi.nlm.nih.gov/pubmed/22260501 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Ergosterol peroxide inhibits ovarian cancer cell growth through multiple pathways. | 2017 |
|
| Ergosterol Peroxide: A Mushroom-Derived Compound with Promising Biological Activities-A Review. | 2017 |
|
| Ergosterol peroxide activates Foxo3-mediated cell death signaling by inhibiting AKT and c-Myc in human hepatocellular carcinoma cells. | 2016-06-07 |
|
| Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer. | 2015-09-15 |
|
| Trypanocidal activity of ergosterol peroxide from Pleurotus ostreatus. | 2012-06 |
|
| Inhibition of STAT3 signaling and induction of SHP1 mediate antiangiogenic and antitumor activities of ergosterol peroxide in U266 multiple myeloma cells. | 2012-01-20 |
|
| Antitumor components from Naematoloma fasciculare. | 2009-10 |
|
| The antiplasmodial activity of isolates from Ajuga remota. | 2002-05 |
|
| Antimycobacterial ergosterol-5,8-endoperoxide from Ajuga remota. | 1999-12 |
|
| [The antiviral action of ergosterol peroxide]. | 1989-08 |
|
| Ergosterol peroxide, an active compound from Inonotus radiatus. | 1989-08 |
|
| [Microbiological isomerization of ergosterol peroxide]. | 1969 |
|
| ISOLATION OF ERGOSTEROL PEROXIDE FROM TRICHOPHYTON SCHOENLEINI. | 1964-06-20 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22260501
Mice: 100 mg/Kg
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10630115
Ergosterol endoperoxide from Ajuga remota showed a minimum inhibitory concentration (MIC) of 1 ug/ml against Mycobacterium tuberculosis.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 18:42:44 GMT 2025
by
admin
on
Wed Apr 02 18:42:44 GMT 2025
|
| Record UNII |
UG9TN81TGH
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
31324
Created by
admin on Wed Apr 02 18:42:44 GMT 2025 , Edited by admin on Wed Apr 02 18:42:44 GMT 2025
|
PRIMARY | |||
|
65858
Created by
admin on Wed Apr 02 18:42:44 GMT 2025 , Edited by admin on Wed Apr 02 18:42:44 GMT 2025
|
PRIMARY | |||
|
5351516
Created by
admin on Wed Apr 02 18:42:44 GMT 2025 , Edited by admin on Wed Apr 02 18:42:44 GMT 2025
|
PRIMARY | |||
|
Ergosterol peroxide
Created by
admin on Wed Apr 02 18:42:44 GMT 2025 , Edited by admin on Wed Apr 02 18:42:44 GMT 2025
|
PRIMARY | |||
|
DTXSID501021533
Created by
admin on Wed Apr 02 18:42:44 GMT 2025 , Edited by admin on Wed Apr 02 18:42:44 GMT 2025
|
PRIMARY | |||
|
UG9TN81TGH
Created by
admin on Wed Apr 02 18:42:44 GMT 2025 , Edited by admin on Wed Apr 02 18:42:44 GMT 2025
|
PRIMARY | |||
|
2061-64-5
Created by
admin on Wed Apr 02 18:42:44 GMT 2025 , Edited by admin on Wed Apr 02 18:42:44 GMT 2025
|
PRIMARY |